Since we were unable to demonstrate OGG1 target engagement in A3 cells in the derived xenograft tumor (Figure 7B), we hypothesized that the lack of in vivo TH5487 efficacy was due to lack of OGG1 target engagement. Here, OGG1 is linked to neoplasm.